A study published in Nature Structural & Molecular Biology has uncovered the structure of resuscitation promoting factor (Rpf), a key player in TB bacteria. The discovery holds promise for developing new methods to 'wake-up' dormant bacteria, allowing antibiotics to kill and cure the disease.
Cassini mission data reveals the formation of molecular oxygen atmospheres in Saturn's rings without life present. This finding suggests that oxygen can be produced through non-biological means, complicating the search for life beyond Earth.
Dr. Walsh will focus on his research on nonribosomal peptide synthetases, which biosynthesize a variety of biologically active peptides. He will discuss the molecular logic of enzymatic assembly lines and tailoring enzymes that modify the peptides.
A research team has published a paper in Science that uses molecular biology to fill gaps in the evolutionary history of bats. The study reveals that megabats originated from four major lineages of microbats, which emerged around 52-50 million years ago.
The ASBMB-Avanti award recognizes Dr. Dowhan's work on lipid-protein interactions, which has expanded our understanding of lipids' roles in cellular processes. His research has established the molecular basis for new lipid functions and impacts a wide range of investigators.
A research team has published a paper in Science magazine that uses molecular biology to illuminate the evolutionary history of bats. The study reveals that large fruit-eating bats (megabats) emerged from four major lineages of smaller, night-flying bats (microbats), with the latter originating around 52-50 million years ago.
Researchers at NIST developed a simple, chemical way to attach electrical contacts to molecular-scale electronic components. The technique, patented by the institute, uses copper ions to form strong, chemically bonded contacts that protect fragile molecules during further metallic vapor deposition steps.
The ASBMB-Merck Award lecture will focus on the role of protein tyrosine phosphatases (PTPs) in cellular signaling and cancer. Recent research has shown that PTPs can function as tumor suppressor genes, with the PTEN gene being a key example.
Researchers at NYU developed a mathematical model that replicates the complex network of molecular interactions within a cell's circadian clock. The study found that rapid binding and unbinding of regulatory molecules is crucial for accurate timekeeping, contradicting the notion that more molecules lead to better accuracy.
Researchers at Johns Hopkins University have developed a new molecular switch that can transform bacteria into working sensors. The device, created using a novel fusion technique, shows promise for detecting cancer cells, releasing drugs, and monitoring chemical or biological agents.
The Max Planck Partner Institute in China will focus on computational biology, training young researchers, and collaborating with Chinese universities. The institute aims to integrate cutting-edge research competencies from both German and Chinese sides.
Researchers found that molecular clock genes Bmal1 and Clock play a crucial role in regulating glucose levels, with suppressing these molecules eliminating diurnal variation. A mutated Clock gene also protected mice from diabetes induced by high-fat diets, suggesting altering meal timing may reduce disease risk.
The Initiative for Science in Europe (ISE) is an independent platform for organizations committed to scientific and technological development. ISE aims to provide a common forum for advocating independent scientific advice in European policy-making and stimulating the involvement of European scientists in shaping science and technology...
A study by Johannes Schwarz and colleagues tracked molecular changes in brains of Parkinson's patients over 7.5 years using SPECT to measure dopamine transporter binding, revealing a single exponential decline rather than linear loss. This advancement enables the development of individualized treatment for advanced Parkinson's patients.
Researchers explored strategies to combat HIV-1 protease resistance, a key factor in treatment failure. The study identified novel approaches to inhibit the enzyme, offering potential solutions to overcome drug resistance and improve treatment outcomes.
Researchers discovered that MMP-1 operates as an extracellular molecular motor converting chemical energy into motion by breaking collagen bonds. This process contributes to tissue growth, development, and repair, and may even aid in cancerous invasion.
María Blasco, a Spanish scientist, was awarded the EMBO Gold Medal for her groundbreaking research on telomeres and cancer. Her work has led to significant discoveries on telomerase RNA component, interplay with DNA repair and cell cycle, and chromatin epigenetics.
A team led by Brown ecologist will study how Arabidopsis integrates environmental signals to flower at favorable times. The research aims to improve food production, understand climate change's impact on crops and wild plants, and shed light on genetic variation.
Researchers have developed a genetic code that enables the evolution of synthetic molecules, revolutionizing drug discovery. By creating a library of nonbiological origin compounds, scientists can identify novel drugs and disrupt cellular processes.
This innovative approach enables visualization of immune system killer cells attacking tumors, providing insights into the immune response. Dr. Witte's collaboration with clinicians and scientists is paving the way for molecular imaging in clinical trials.
The detection of molecular nitrogen in interstellar clouds promises to enhance our knowledge of interstellar chemistry and the formation of planets. FUSE, a satellite-telescope designed at Johns Hopkins, allowed astronomers to probe dense clouds where N2 is expected to be dominant.
Scientists at Brown University have identified two molecular mechanisms that trigger senescence in aging cells. The discovery of p16, a protein that operates independently from telomeres, provides new insights into the regulation of cell division and holds promise for the development of therapeutics to manipulate these targets.
The Max Planck Research Prize recognizes the work of Martin Vingron and Eugene W. Myers in bioinformatics, enabling precise gene expression analysis and tailored therapies. The prize honors international cooperation in this field, providing significant research funding.
The joint program aims to expand technical capabilities in systems biology by combining ISB's instrumentation expertise with PNNL's computational powers. Current collaborations include protein structure prediction and whole proteome analysis, with potential applications in disease diagnosis and prevention.
Researchers from Hebrew University and UCLA successfully created a tiny molecular motor that can be halted, paving the way for nanoscale devices with high precision. The achievement uses light or electrical stimulation to rotate a molecule, opening up possibilities for industrial and surgical applications.
A new tumor classification system combines molecular biology and classic pathology to provide a comprehensive and consistent way of typing tumors. The system uses both the type of cells that form a tumor and its molecular characteristics to determine its behavior, offering improved accuracy and insight into treatment options.
Dr. Paul Sharpe has received the 2004 Craniofacial Biology Award for his pioneering work in vertebrate body patterning and the molecular basis of tooth development. His contributions to the field have been widely accepted by the scientific community, recognizing his significant impact on craniofacial biology.
Virginia Tech biologist Virginia Tyson earns top scientist award for his work in computational cell biology and mathematical models of molecular mechanisms controlling cellular growth and division. His research aims to understand and treat medical problems caused by molecular dys-regulation, such as cancer and nerve-cell regeneration.
The new center will integrate basic molecular and cellular research with advanced imaging technologies and computational science to understand complex biological systems. This collaboration aims to develop computer models of entire cells, revolutionizing drug development and reducing costs.
The EMBC has agreed to a six-year budget for EMBO, providing stability for European molecular biology research. This agreement was reached after earlier proposals requested higher funding levels, but ultimately, a compromise was made to support the organization's activities and promote scientific advancements in Europe.
A team of scientists has identified a cluster of 88 genes that may act as molecular markers for the developmental potential of different stem cell types and stages. These findings are consistent with previous research on cellular development and plasticity, and shed light on the molecular pathways guiding development.
Researchers found that elevated molecular chaperones promote longevity in C. elegans, a roundworm whose biochemical environment is similar to humans. This suggests that brief exposure to environmental and physiological stress can have long-term benefits to cells by unleashing molecular chaperones.
Researchers have demonstrated that molecular memories are both durable and practical, with test results showing they can survive high temperatures and up to 1 trillion operational cycles. This finding could spur development of molecule-based memory devices, promising smaller, faster, and more powerful computers.
Researchers develop protein profiles to classify gliomas and predict aggressiveness with high accuracy. The 'molecular fingerprint' can help tailor treatment decisions for patients, distinguishing between aggressive and less aggressive tumors.
A new study by researchers at The Wistar Institute shows that gene activation is a highly dynamic process requiring specific molecular modifications, including the addition and removal of ubiquitin. This process involves a sequence of events and not just the accumulation of molecular groups.
A study published in Molecular Psychiatry found that a specific gene variant, M129V, affecting the prion protein is associated with changes in cognitive performance. Researchers discovered this link while investigating genetic influences on mental health disorders, also noting a connection to mad cow disease.
A team of researchers led by Dr. Sharyn Endow at Duke University Medical Center has discovered the power stroke that drives molecular motors, which transport nutrients around cells or herd chromosomes during cell division. This breakthrough could help understand diseases like Down's syndrome and prevent them.
Researchers at SLU have successfully deciphered the molecular structure of recombination protein O (RecO), crucial for accurate genomic DNA replication. This breakthrough may aid pharmaceutical researchers in developing more effective drugs and basic scientists in understanding gene function.
Anthony Hyman, group leader at Max Planck Institute of Molecular Cell Biology and Genetics, wins prestigious EMBO Gold Medal. His research focuses on microtubules' role in cell division, shedding light on their dynamics and functions.
Researchers at Max Planck Institute for Cell Biology and Genetics in Dresden and EMBL in Heidelberg have counted the number of proteins that help an egg cell divide. They found that there are more motors pulling on one side, which can pull the centrosome off-center, leading to proper development of the embryo.
Researchers identify key genes and cellular pathways contributing to schizophrenia, providing new insights into the disorder's complex biology. The study's findings hold promise for developing novel therapeutic strategies.
The UCLA Center for Astrobiology will focus on four themes: extrasolar planetary systems, habitability of planets and their satellites, Earth's early environment and life, and evolution of biological complexity. The center aims to detect planets beyond our solar system using new methods and study the factors that control habitability.
The European Molecular Biology Laboratory (EMBL) and EMBO have agreed on a framework for cooperation, paving the way for formal agreements among member states. This development is expected to strengthen bioscience research in Europe, with the aim of supporting innovative projects and promoting collaboration.
The June issue of Plant Physiology features UCR's Center for Plant Cell Biology, which addresses fundamental questions in plant biology through interdisciplinary approaches. The center's work has significant implications for understanding plant cell function and responses to environmental changes.
Haugland's work at Molecular Probes led to the creation of over 2,800 products for biomedical research. He holds 60 patents and authored Handbook of Fluorescent Probes and Research Chemicals.
The EMBO organization rewards a communicator with a silver medal and 5,000 euros for an imaginative and original work. The prize aims to promote molecular biology studies in Europe and recognize the value of communication skills.
The UC Riverside Department of Biology has received a $953,000 GAANN grant to support K-12 outreach efforts. The grant will enable approximately 30 graduate students to participate in research and teaching opportunities while focusing on their Ph.D. degrees.
Researchers discovered that Rad54 and Rad51 proteins form a molecular machine that can repair DNA damage by moving nucleosomes along the strand and stitching new DNA into place. This process becomes more efficient with the addition of Rad51, which binds to single strands of DNA.
Dr. Nie constructs smart nanoparticle probes to recognize DNA sequences and genetic mutations, enabling early cancer diagnosis and personalized medicine. The nanobeacons can profile multiple genes and proteins simultaneously, allowing for individualized cancer treatments based on molecular differences.
Functional nanoparticles are being developed for molecular imaging, cancer treatment, and tissue engineering. Scientists can engineer nanoparticles to have multiple functions, including tagging proteins or genetic sequences in a process called multiplexing.
Nei's work has developed statistical methods to study genetic diversity, evolutionary relationships, and species divergence. He pioneered the neighbor-joining method for constructing phylogenetic trees, widely used worldwide.
A multicenter study identified a positive association between obsessive-compulsive disorder (OCD) and a serotonergic receptor gene variant. This genetic phenotype may represent an early onset risk factor for the disorder, suggesting age of onset should be considered in molecular genetic studies.
The EMBO World Programme fellowship scheme supports scientists from non-European countries to visit European laboratories for a six to nine month period. The program aims to foster collaborations and strengthen research between European and home countries.
Researchers have developed a new technology using firefly light to monitor herpes infections in mice, allowing for repeated tracking over time without sacrificing animals. This non-invasive method enables the investigation of viral populations and immune system influences.
Researchers at Washington University's Molecular Imaging Center are developing new applications for existing technologies like PET scans. They're also exploring new methods of molecular imaging using near-infrared fluorescence and bioluminescence probes to study protein-protein interactions, immune cells attacking tumors, and the cours...
Scientists are exploring how molecular genetics can improve classical biological control by finding natural enemies well adapted to target invasive pests. Genetically modified crops with toxins like Bt may also be compatible with natural enemies, offering a new approach to controlling unwanted insect pests.
Sydney Brenner's groundbreaking research on Caenorhabditis elegans revealed genes controlling human processes, while his contributions to molecular biology and systems biology paved the way for major discoveries. His work at the Molecular Sciences Institute continues to advance our understanding of biological systems.
A research team has visualized the interactions between molecular chaperones and protein aggregates, shedding light on how these protective proteins prevent disease. The study provides new insights into neurodegenerative diseases and could lead to the development of effective drugs.
A team of researchers will study the role of Rac2, a protein important in phagocytic blood cell function, using mice that lack a functional Rac2 gene and exhibit immune system defects. The long-term goal is to develop novel approaches to control phagocyte function and disease.
Researchers at The Wistar Institute have identified a new enzyme required for silencing certain genes, which can lead to cancer. The discovery could lead to new cancer therapies by targeting the enzyme's activity.